Loading chat...
MN HF2056
Bill
Status
Introduced
3/9/2021
Primary Sponsor
Michael Howard
Click for details
AI Summary
-
Health plans that impose co-payments on prescription drugs must limit co-payments to $25 per one-month supply for drugs prescribed to treat chronic disease and related medical supplies necessary to administer those drugs.
-
Chronic disease is defined as diabetes, asthma, and allergies requiring the use of epinephrine auto-injectors.
-
The provision becomes effective January 1, 2022, and applies to health plans offered, issued, and renewed on or after that date.
Legislative Description
Prescription drug and medical supplies co-payment for chronic disease treatment limited.
Last Action
Author added Bierman
4/8/2022
Committee Referrals
Health Finance & Policy3/17/2021
Commerce Finance & Policy3/9/2021
Full Bill Text
No bill text available